Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
04/28/20175:07PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/26/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals to Hold First Quarter 2017 Financial Results Conference Call and Webcast on Monday, May 8th, 2017NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/13/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals Reports Publication of Manuscripts Analyzing IV, Transdermal and Sublingual Patient-Controlled Analges...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/11/20175:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/06/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals Presenting Comprehensive DSUVIA Clinical Trial Results at ASRA's Annual Regional Anesthesiology and Ac...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/28/20177:00AMPR Newswire (US)European Medicines Agency Begins Evaluation of Marketing Application for Sublingual Sufentanil 30 mcg Tablet (ARX-04) for Mod...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/17/20171:15PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/17/20171:15PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/17/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in March and AprilNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/16/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals Presents Efficacy and Pharmacokinetics of DSUVIA™ at Upcoming CongressesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/10/20177:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/07/20174:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/07/20174:35PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/07/20176:05AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/07/20176:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/03/20176:07AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/02/20174:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/01/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in MarchNASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/27/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals' New Drug Application for DSUVIA Accepted for Filing with PDUFA Date of October 12, 2017NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/23/20174:01PMPR Newswire (US)AcelRx Pharmaceuticals to Hold Annual 2016 Financial Results Conference Call and Webcast on Thursday, March 2nd, 2017NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/16/20174:48PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/16/20174:45PMPR Newswire (US)AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive OfficerNASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/15/20177:09AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/14/20175:59PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/13/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals Presentation at JAB Burn Symposium Highlights Potential of DSUVIA™ for Use in Burn Victims with Mode...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/09/20175:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/07/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals to Participate at Four Upcoming Investor Events in FebruaryNASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/27/201710:32AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/09/20176:19AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/08/20178:02AMPR Newswire (US)AcelRx Pharmaceuticals Provides Guidance on 2017 Milestones for ARX-04, now known as DSUVIA™ in the United States, for the ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX